Fatigue in rheumatoid arthritis is highly prevalent. It is correlated only weakly with disease
activity but more so with pain, mood, personality features, poor sleep, obesity and …

Fatigue is a common constitutional feature of systemic lupus erythematosus (SLE) and
rheumatoid arthritis (RA). While the two diseases share a common mechanism of …

Rheumatoid arthritis (RA) management is driven by evidence, and new 2019 EULAR
recommendations help in refining the relevant place of different disease-modifying anti …

Objective To test the ability of machine learning (ML) approaches with clinical and genomic
biomarkers to predict methotrexate treatment response in patients with early rheumatoid …

Background and objective No clinical trial has examined the risk of infection associated
methotrexate and azathioprine, two advocated treatments for sarcoidosis. We aimed to …

Psoriatic arthritis (PsA) is a heterogeneous chronic musculoskeletal disease, affecting up to
30% of people with psoriasis. Research into PsA pathogenesis has led to the development …

Objectives To estimate prevalence rates and identify baseline predictors of adverse events
(AEs) over the first year of treatment in patients with RA starting MTX. Methods Data came …

Objectives This systematic review aims to summarize rates of adverse events (AEs) in
patients with RA or inflammatory arthritis starting MTX as monotherapy or in combination …

Janus kinase inhibitors (JAKis) are a group of drugs with a different mechanism of action
from biologics and are most rapidly uptaken in the rheumatology field. JAK is a protein …

Introduction The magnitude and frequency of temporally related methotrexate (MTX)-
associated side effects in rheumatoid arthritis (RA) or psoriatic arthritis (PsA) patients are …